These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 3105859
1. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec. Scriver CR, Gregory D, Bernstein M, Clow CL, Weisdorf T, Dougherty GE, Auray-Blais C, Giguère R, Lemieux B, Laberge C. CMAJ; 1987 May 01; 136(9):952-6. PubMed ID: 3105859 [Abstract] [Full Text] [Related]
2. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG. Pediatrics; 1990 Nov 01; 86(5):765-73. PubMed ID: 2152340 [Abstract] [Full Text] [Related]
3. Neuroblastoma: the case for screening infants in North America. Woods WG, Tuchman M. Pediatrics; 1987 Jun 01; 79(6):869-73. PubMed ID: 3588142 [Abstract] [Full Text] [Related]
4. Screening for neuroblastoma in North America--preliminary results from the Quebec project. Woods WG, Tuchman M, Lemieux B. Prog Clin Biol Res; 1991 Jun 01; 366():585-94. PubMed ID: 2068177 [No Abstract] [Full Text] [Related]
5. Screening for neuroblastoma (NB) in North America: the Quebec Project. Woods WG, Lemieux B, Leclerc JM, Bernstein ML, Brisson L, Brossard J, Brodeur GM, Look AT, Robison LL, Shuster JJ. Prog Clin Biol Res; 1994 Jun 01; 385():377-82. PubMed ID: 7972234 [No Abstract] [Full Text] [Related]
6. Compliance in a screening program for neuroblastoma. Campion P, Woods WG, Lemieux B. Prev Med; 1998 Jun 01; 27(4):590-6. PubMed ID: 9672953 [Abstract] [Full Text] [Related]
7. Screening of infants and mortality due to neuroblastoma. Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B. N Engl J Med; 2002 Apr 04; 346(14):1041-6. PubMed ID: 11932470 [Abstract] [Full Text] [Related]
8. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine. Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J. Jpn J Clin Oncol; 1987 Jun 04; 17(2):151-5. PubMed ID: 3613139 [Abstract] [Full Text] [Related]
9. A pilot study of screening for neuroblastoma in the north of England. Craft AW, Parker L, Dale G, McGill AC, Seviour JA, Bell S, Cole M, Smith J. Am J Pediatr Hematol Oncol; 1992 Nov 04; 14(4):337-41. PubMed ID: 1456400 [Abstract] [Full Text] [Related]
10. Screening for neuroblastoma in the northern region of England. Laboratory aspects. Seviour JA, McGill AC, Craft AW, Parker L, Bell S, Cole M, Smith J, Hawkins E, Brown J, Dale GA. Am J Pediatr Hematol Oncol; 1992 Nov 04; 14(4):332-6. PubMed ID: 1456399 [Abstract] [Full Text] [Related]
11. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma. Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J. Jpn J Clin Oncol; 1987 Sep 04; 17(3):221-8. PubMed ID: 3669365 [Abstract] [Full Text] [Related]
12. A population-based study of the usefulness of screening for neuroblastoma. Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Byrne T, Weitzman S, Bunin G, Lemieux B. Lancet; 1987 Sep 04; 348(9043):1682-7. PubMed ID: 8973429 [Abstract] [Full Text] [Related]
13. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old. Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J. Jpn J Clin Oncol; 1986 Dec 04; 16(4):351-5. PubMed ID: 3795531 [Abstract] [Full Text] [Related]
14. [The "Lower Saxony/Northern Rhine-Westphalia" Neuroblastoma Screening Project: on the need for epidemiologic comparison]. Berthold F, Sander J, Baillot A, Hunneman DH, Michaelis J. Klin Padiatr; 1992 Dec 04; 204(4):288-92. PubMed ID: 1518267 [Abstract] [Full Text] [Related]
15. [Early neuroblastoma detection in Germany. On the status of the Hamburg-Stuttgart cooperative pilot study]. Schilling FH, Erttmann R, Dohrmann S, Erb N, Winkler K, Gross U, Treuner J. Klin Padiatr; 1992 Dec 04; 204(4):282-7. PubMed ID: 1518266 [Abstract] [Full Text] [Related]
16. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma. Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T. Jpn J Clin Oncol; 1990 Sep 04; 20(3):268-70. PubMed ID: 2255102 [Abstract] [Full Text] [Related]
17. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society]. Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A. Gan To Kagaku Ryoho; 1990 Dec 04; 17(12):2319-26. PubMed ID: 2260868 [Abstract] [Full Text] [Related]
18. Mass screening of neuroblastoma in Sapporo City, Japan. Nishi M, Miyake H, Takeda T, Kikuchi Y, Hanai J, Yonemori H, Takasugi N. Am J Pediatr Hematol Oncol; 1992 Nov 04; 14(4):327-31. PubMed ID: 1456398 [Abstract] [Full Text] [Related]
19. Results of mass screening for neuroblastoma in Sapporo, Japan. Takeda T, Nishi M, Shimada M, Nakadate H, Hatae Y, Naito H, Hanai J, Kawai T, Takasugi N. Prog Clin Biol Res; 1991 Nov 04; 366():595-601. PubMed ID: 2068178 [No Abstract] [Full Text] [Related]
20. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants. Schilling FH, Oberrauch W, Schanz F, Treuner J. Prog Clin Biol Res; 1991 Nov 04; 366():579-83. PubMed ID: 2068176 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]